ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      68,721.93
      1.19%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSXV

      6. Nurexone Biologic Inc (NRX) Quote

      Nurexone Biologic Inc

      Nurexone Biologic Inc (NRX)

      Noronex Limited
      0.61
      -0.02
      (-3.17%)
      Closed July 27 4:00PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.61
      Bid
      0.61
      Ask
      0.65
      Volume
      99,600
      0.61 Day's Range 0.65
      0.185 52 Week Range 1.19
      Market Cap
      29.432M
      Previous Close
      0.63
      Open
      0.64
      Last Trade
      2000
      @
      0.61
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      73,885
      Shares Outstanding
      48,249,000
      Dividend Yield
      -
      PE Ratio
      -8.09
      Earnings Per Share (EPS)
      -0.08
      Revenue
      -
      Net Profit
      -3.64M

      About Nurexone Biologic Inc

      Sector
      Miscellaneous Metal Ores,nec
      Industry
      Pharmaceutical Preparations
      Website
      www.nurexone.com
      Headquarters
      Toronto, Ontario, Can
      Founded
      2011
      Nurexone Biologic Inc is listed in the Miscellaneous Metal Ores sector of the TSX Venture Exchange with ticker NRX. The last closing price for Nurexone Biologic was $0.63. Over the last year, Nurexone Biologic shares have traded in a share price range of $ 0.185 to $ 1.19.

      Nurexone Biologic currently has 48,249,000 shares outstanding. The market capitalization of Nurexone Biologic is $30.40 million. Nurexone Biologic has a price to earnings ratio (PE ratio) of -8.09.

      NRX Latest News

      More News

      Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma

      TORONTO and HAIFA, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

      July 17 2024
      GlobeNewswire Inc.

      Updates from NurExone: Growth Conference Presentation and Website Relaunch

      TORONTO and HAIFA, Israel, July 05, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

      July 05 2024
      GlobeNewswire Inc.

      NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market

      TORONTO and HAIFA, Israel, June 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

      June 28 2024
      GlobeNewswire Inc.

      On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development

      TORONTO and HAIFA, Israel, June 21, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

      June 21 2024
      GlobeNewswire Inc.

      NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application

      TORONTO and HAIFA, Israel, June 11, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

      June 11 2024
      GlobeNewswire Inc.

      NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders

      TORONTO and HAIFA, Israel, June 04, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

      June 04 2024
      GlobeNewswire Inc.

      NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials

      TORONTO and HAIFA, Israel, May 29, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company...

      May 29 2024
      GlobeNewswire Inc.

      NurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive Strategic Collaborations

      TORONTO and HAIFA, Israel, May 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

      May 17 2024
      GlobeNewswire Inc.

      Shares of Biopharma Up After News of Uplisting

      When firms uplist to a higher exchange, they gain visibility and greater access to investors. And today, news of a strategic expansion in the United States is sending shares of this biopharma To...

      April 25 2024
      AllPennyStocks.com

      Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies

      For anyone with a spinal cord injury (SCI), time is of the essence. The typical treatment scenario involves immobilization and surgery as quickly as possible. After that, managing To read the full...

      November 16 2023
      AllPennyStocks.com
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.11-15.27777777780.720.720.61340150.69086244CS
      4-0.04-6.153846153850.650.750.61638940.69738412CS
      120.011.666666666670.60.870.46738850.68370508CS
      260.315106.7796610170.2951.190.271250400.76098878CS
      520.3051000.3051.190.185816370.73577511CS
      156-0.19-23.750.81.190.1553420.70585004CS
      260-0.19-23.750.81.190.1553420.70585004CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WINTWindtree Therapeutics Inc
      $ 8.24
      (150.46%)
      		48.57M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.1349
      (92.71%)
      		122.1k
      YIBOPlanet Image International Ltd
      $ 2.915
      (53.43%)
      		260.07k
      CREVCarbon Revolution Public Ltd
      $ 9.00
      (45.87%)
      		8.06M
      NMHINatures Miracle Holding Inc
      $ 0.2035
      (-48.06%)
      		7.69M
      TANHTantech Holdings Ltd
      $ 0.2585
      (-47.23%)
      		6.75M
      DXCMDexCom Inc
      $ 64.00
      (-40.66%)
      		53.92M
      PSIGPS International Group Ltd
      $ 1.42
      (-31.40%)
      		716.26k
      POAIPredictive Oncology Inc
      $ 1.36
      (-27.27%)
      		6.02M
      SLNASelina Hospitality PLC
      $ 0.0305
      (-18.88%)
      		408.61M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NVDANVIDIA Corporation
      $ 113.06
      (0.69%)
      		293.33M
      SQQQProShares UltraPro Short QQQ
      $ 9.10
      (-2.88%)
      		176.49M
      SGMOSangamo Therapeutics Inc
      $ 0.8612
      (28.15%)
      		123.71M

      Discussion

      View Full Feed
      spdpro spdpro 5 minutes ago
      D > Lots of "monkey business" goes on in btc >
      I need to use some compare charts to make any sense of it's moves and / or possible "ranges" >
      Also what really moves and effects btc other than a bunch of machines at war with each other >
      I can easily see how someone can loose tho
      Bob Mullet Bob Mullet 5 minutes ago
      Let’s have a timeline on that. It’s been 18 years since this project started.

      Whats a reasonable timeframe for company formation to product being sold?

      20 years?

      That would be a reasonable expectation, for a company funded by dilution.
      KBLB
      cojoboy cojoboy 5 minutes ago
      O.K...lets Not send lucky there.
      RONN
      alidare alidare 6 minutes ago
      Did “we” see this coming?

      https://twitter.com/mmatnews/status/1817298069844611458?s=46&t=800C1sKBzgngFkbiaBx4-A

      AABB
      IceCold8 IceCold8 6 minutes ago
      Trump did his job @ the crypto conference,Logan do yours!!! Enough with the hiding,do right by your shareholders,or get out the way and file for bankruptcy.
      CGAC
      SilkRoad SilkRoad 7 minutes ago
      I’m starting to wonder if WebSlinky is a China plant.
      KBLB
      cojoboy cojoboy 7 minutes ago
      Careful.. Grasshopper..No Henry..No Youse..
      PHIL
      TRAPPER JIM TRAPPER JIM 8 minutes ago
      They lost the first game and won the second one. They play again at nine oclock tomorrow morning
      javi2003 javi2003 9 minutes ago
      You might be right look at the accumulation volume. It’s already been rising quietly and slowly the same pattern that we saw before.
      BFCH
      Energy Manager Energy Manager 11 minutes ago
      Lock it up...!

      I've been purchasing this stock for years, and didn't sell a share when it went to $10 a couple years ago.

      I guess you can say I have "Lonsdaleite" hands, as the meme stock traders refer to Diamond hands. $40 a share would put this at a modest market c
      LCTC
      MetaMonster MetaMonster 11 minutes ago
      New blood on deck Many eyeballs watching
      RNAZ
      MightyX MightyX 12 minutes ago
      Agreed
      TPTW
      fuagf fuagf 13 minutes ago
      livefree_ordie, One, the Fair Tax idea is not yours, have always felt one should only accept credit where it is due. Two, it is a lousy idea. It would make much more sense for the world to go back to the fairer tax rates of the 50s early 60s, as Rutger Bergman suggests here .. https://investorshub
      HGilS HGilS 14 minutes ago
      Thanks Lazarus. Thanks sharkey.

      Just in time
      ELTP
      oystersnbeer oystersnbeer 15 minutes ago
      https://x.com/GenoVeno73/status/1816630791859839459

      https://x.com/EricMaclin/status/1816876930521575632
      somberfox somberfox 15 minutes ago
      Possibly.

      They got 4 days before July is over. Guess we'll see.
      CLNV
      KILLAZILLA KILLAZILLA 15 minutes ago
      LOLOLOLOL...YES IT IS!!! AS WELL AS COH!!!
      "share price is not the barometer of success"

      THEN WHY DO you POST CRAP...ALL THE TIME!!!
      "losers should never advise anyone!"
      WDLF
      abew4me abew4me 15 minutes ago
      Very encouraging. Can you share some of the names of the companies that you worked for?
      AVXL
      arizona1 arizona1 16 minutes ago
      https://twitter.com/gtconway3d/status/1816890419789041731?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1816890419789041731%7Ctwgr%5E5113650c273a3db1158b6e3fc0339fe77e27ea24%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D174819386
      noradio noradio 17 minutes ago
      Can you imagine how many companies and individuals these shorts have destroyed just for $$$. Hell awaits them after this very short life. I wouldn't do what they do even for a trillion dollars...
      ERHE
      Welcome2Pinkyland Welcome2Pinkyland 18 minutes ago
      We have a difference of opinion. That's ok with me.
      BullNBear52 BullNBear52 18 minutes ago
      Michael King just stellar today. Another pitcher Cashman traded away.
      BullNBear52 BullNBear52 20 minutes ago
      More importantly Chisholm has a higher OBP and steals more bases

      He has stolen 4 more bases than Volpe. His OBP is only 18 points higher. Volpe has a higher BA. And you think he should be awarded the leadoff position.

      You obviously don't know anything about team chemis

      Your Recent History

      TSXV
      NRX
      Nurexone Biologic
      Delayed Upgrade Clock